Mark Schoenberg, Chief Medical Officer at UroGen Pharma Ltd. (URGN), sold 10,000 shares at $25.00 ($250K) on 2025-11-19, disclosed to the SEC on 2025-11-20.
Scheduled sale ($250k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| URGN | SELL | 2026-07-10 | $400K | — | Filing → |
| URGN | SELL | 2026-06-24 | $350K | — | Filing → |
| URGN | SELL | 2026-06-09 | $143K | — | Filing → |